Investigators have identified the same p53 gene mutation in urothelial carcinomas of the upper and lower urinary tracts, that is, tumor cells containing the mutated gene were implanted into the bladder epithelium and migrated and spread in a monoclonal manner (24). This evidence concerns the gene TP53 and urothelial carcinoma.